Kygevvi is indicated for patients with thymidine kinase 2 deficiency whose symptoms arise by 12 years of age. The disease ...
Gastrointestinal distress should not be ignored. When identified and managed early, they can make all the difference in ...
Salicylic acid (SA) plays a pivotal role in plant defense, yet its genetic regulation in tea remains largely unexplored. By ...
A groundbreaking FDA approval offers the first-ever treatment for ultra-rare Thymidine Kinase 2 Deficiency (TK2d). KYGEVVI, a ...
"I wish a doctor had mentioned this as a possible side effect. I thought I had asked the correct questions and was on one of ...
After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...
Season of Sustainability: Crown's Commitment on World Environment Day and BeyondAlongside the launch of our 2024 Sustainability ...
Associated British Foods plc ( OTCPK:ASBFY) Q4 2025 Earnings Call November 4, 2025 4:00 AM EST ...
BOCA RATON, FL / ACCESS Newswire / October 30, 2025 / Entero Therapeutics (NASDAQ:ENTO) has just made one of the boldest moves in its history, a reinvention that trades long biotech timelines for imme ...
The presence of metabolic dysfunction-associated steatotic liver disease may be a predictor of disease trajectory in patients with MACE.
Objectives Disease activity assessment is important for Crohn’s disease (CD) management, since it involves the initial and subsequent therapeutic schedule. The purpose of this study is to identify a ...